Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13658725 | 0.86 | SMN1; SMN2 (0.50) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL275959 | 0.83 | SMN1; SMN2 (0.48) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL17426595 | 0.83 | SMN1; SMN2 (0.52) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL14986331 | 0.82 | AHR (0.40) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL12014521 | 0.82 | KDM4E (0.44) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL12571761 | 0.82 | KDM4E (0.51) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL24812258 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL10030067 | 0.81 | SIRT2 (0.47) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL15977771 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2KDM4ELMNAMAPTPKM | |
| SCHEMBL17227628 | 0.81 | SMN1; SMN2 (0.50) | SMN1; SMN2KDM4ELMNAMAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2213640-B1 | BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO (JP) | 2016-10-05 | — | — | EP | disclosed |
| US-8253129-B2 | Benzochrysene derivative and an organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-8253129-B2 | Benzochrysene derivative and an organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20100295029-A1 | BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. | 2010-11-25 | — | — | US | disclosed |
| US-20100295029-A1 | BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100295029-A1 | BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | KSR1, NRAS, RSU1 | SMN1; SMN2 3183/4885KDM4E 2471/4885LMNA 3864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.